Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration
Press release content from PR Newswire. The AP news staff was not involved in its creation. Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration December 18, 2020 GMT TOKYO and NANJING, China, Dec. 18, 2020 /PRNewswire/ -- Teijin Pharma Limited (“Teijin Pharma”), the core company of the Teijin Group ’s healthcare business headquartered in Tokyo, Japan, and TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in Nanjing, China, jointly announced that they have entered into a strategic collaboration agreement for joint resea...
Source: apnews.com